BiophysicsbioRxivPreprint
High Throughput Virtual Screening and Validation of a SARS-CoV-2 Main Protease Non-Covalent Inhibitor
A. Clyde, S. Galanie, D. W. Kneller…·R. Stevens
This paper identifies a novel non-covalent inhibitor of SARS-CoV-2 main protease through high throughput virtual screening, validated by biochemical assays, X-ray crystallography, and molecular dynamics simulations.
DOI 10.1101/2021.03.27.437323